{"disease":{"id":"moderate-and-severe-plaque-psoriasis","name":"moderate and severe plaque psoriasis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03424629","title":"Safety and Efficacy of UC-MSCs in Patients With Plaque Psoriasis","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":57,"lead_sponsor_name":"Tianjin Ever Union Biotechnology Co., Ltd.","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}